Deutsche Telekom backs Swedish AI health specialist Tandem Health

Deutsche Telekom has invested an undisclosed sum in Tandem Health, taking a position in the Swedish developer's Series B round through its T.Capital corporate investment arm and adding AI healthcare to a portfolio that now reaches into the clinical back office.

The target of the deal is a medical records assistant already deployed in more than 10,000 healthcare facilities across Europe. The platform provides access to clinical documents, coding and decision-making tools, and it is integrated into roughly 130 electronic health record systems. Tandem Health says the product meets stringent European Union regulations governing healthcare data and the bloc's sovereignty requirements — a compliance position that matters for any operator hoping to sell digital health services into EU public-sector customers.

Why is a telecom operator buying into medical software?

Deutsche Telekom is not simply placing a financial bet. The group's T-Systems unit runs a health industry business under SVP Gottfried Ludewig, who also heads the public sector division, and the operator reasons that AI could relieve administrative burdens in healthcare and in turn improve efficiency at healthcare facilities. Health is one of the verticals European carriers have targeted as they look to grow enterprise revenue beyond connectivity.

Karine Peters, managing director of T.Capital, framed the investment around workflow. Tandem Health's platform, she said, "noticeably reduces the administrative burden on healthcare professionals" without compromising on "quality, safety and compliance" standards. She added that the company expects AI to "play a key role in addressing the challenges facing healthcare".

What does the administration problem look like in practice?

Tandem Health surveyed healthcare professionals and patients late in 2025, and the findings sketch the burden its product targets. Administration tasks take up a sizeable chunk of clinicians' working day. Most healthcare staff told the company they would prefer to spend more time with patients than on paperwork, and more than half expressed concern over the quality of the interactions they do have. On the other side of the desk, patients reported worries about distracted doctors and inaccurate information.

The survey results are vendor-commissioned research, but they align with a well-documented European policy concern: health systems face staff shortages and rising documentation loads, and Brussels has made digital health interoperability a stated priority.

Trust remains the gating condition

Deutsche Telekom itself is careful not to oversell the technology. Ludewig emphasised that any AI systems employed in healthcare must be trustworthy and secure. That condition sits at the centre of the EU's regulatory approach, where the AI Act imposes strict obligations on high-risk applications in medical settings and data sovereignty rules push public health buyers toward European providers.

For Tandem Health, that regulatory environment is arguably a commercial asset rather than a barrier. Integration into 130 electronic health record systems and certification against EU rules create switching costs and a compliance moat that non-European rivals must replicate deal by deal.

The financial terms of the Series B round, including its total size and Deutsche Telekom's stake, were not disclosed. Neither company set out a deployment timeline tied to the investment. What the deal does establish is Deutsche Telekom's intent to couple its capital with its public-sector sales channel in European healthcare, a market where the operator will now push AI-enabled administrative tools alongside its connectivity and cloud offerings.